NT5C2 p.Arg29Ter
c.85C>T · rs587777173 · VCV100904
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 3 of 19 |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.5 | GERP 0.76, phastCons 1 |
| Overall | ||
| CADD | 40.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NT5C2
- Protein
- p.Arg29Ter
- Coding
- c.85C>T
- MANE Select
- NM_001351169
- dbSNP
- rs587777173
- Type
- single nucleotide variant
- Location
- chr10:103174874 (GRCh38)
- Gene constraint
- LOEUF 1.128 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 88.81 · 43 PDB
Disease context
hereditary spastic paraplegia 45 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Autosomal recessive spastic paraplegia type 45 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy
Similar variants
- NT5C2 c.1449+2T>C Pathogenic/Likely pathogenic ★★ same condition
- NT5C2 p.Arg144Ter Pathogenic/Likely pathogenic ★★ same condition
- NT5C2 p.Arg367Ter Pathogenic/Likely pathogenic ★★ same condition
- NT5C2 p.Arg39Ter Pathogenic ★★ same condition
- NT5C2 c.176-11T>A Uncertain significance ★★ same condition
- NT5C2 c.390-3C>T Uncertain significance ★★ same condition
- NT5C2 p.Arg28His Uncertain significance ★★ ⚠ same condition
- NT5C2 p.Asp229His Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nt5c2-p-arg29ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown